WEIGHT LOSS MEDICATIONS REDUCE COLON CANCER RISK Newly completed research published in the scientific journal JAMA Oncology Journal of the hellip

ZEPBOUND THE NEW WEIGHT LOSS MEDICATION The FDA has just published a news release regarding its approval of Zepbound hellip

A comparison of two drugs used to treat type 2 diabetes found that tirzepatide Mounjaro was superior to semaglutide Ozempic at blood hellip

Polycystic Ovarian Syndrome PCOS is a condition of hormonal imbalance that is characterized by menstrual cycle irregularity weight gain fertility problems hellip

Wegovy Ozempic and Mounjaro Surging demand for drugmaker Novo Nordisk s highly popular diabetes treatments Ozempic and Wegovy now being used hellip

Tirzepatide Tirzepatide Mounjaro ia a once weekly GIP glocose dependent insulinoptropic polypeptide0 receptor and GLP 1 glucagon like peptide 1 receptor agonist Tirzepatide activates the body 8217 s receptors hellip